After PEPFAR: Africa’s HIV Safety Net Under Strain

2026-07-31

The quiet part is now loud: many African health systems were never ready to stand without PEPFAR. Five year sustainability plans existed on paper, mapping a shift from donor funded vertical HIV programs into routine primary care, but the political timetable, not the technical one, has started to rule.

The hard truth is that integration is an expensive science project, not a tidy policy slogan. To move antiretroviral therapy, viral load monitoring and differentiated service delivery into everyday clinics, governments must assume line items for commodities, laboratory reagents and community health workers that had long sat in foreign budgets, while also maintaining pharmacovigilance and supply chain management that match donor standards. Health economists warn that fiscal space analyses were often optimistic, built on revenue projections that have since faded, leaving ministries to juggle HIV, immunization and noncommunicable disease packages inside a single essential benefits basket.

The deeper worry is political, not technical. When HIV care becomes just one service among many in understaffed primary facilities, queue length, stockouts and clinician burnout can quietly erode adherence and viral suppression, even if guidelines remain impeccable. Civil society groups argue that the very success of PEPFAR created an expectation of ring fenced attention; once that exceptionalism is withdrawn, accountability becomes diffuse, and no official is clearly answerable for a missed refill or a failed laboratory test. In that ambiguity sits the real test of any post PEPFAR world.

Recommendations